Major shareholder announcement
26 juin 2024 08h08 HE
|
Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis, that as of June 21, BlackRock, Inc. crossed the 5% threshold...
Trading by management and close relations of management
21 juin 2024 05h54 HE
|
Novozymes A/S
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Major shareholder announcement
21 juin 2024 05h53 HE
|
Novozymes A/S
June 21, 2024 Company announcement No. 22 Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that Novo Nordisk Fonden has on its own behalf and on behalf of its...
The era of biosolutions. Outlook upgraded for 2024
17 juin 2024 13h09 HE
|
Novozymes A/S
Novonesis is performing very well and the 2024 outlook for pro forma organic sales growth is now expected at the upper end of the 5-7% range while the pro forma adjusted EBITDA margin is increased to...
Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees
06 juin 2024 05h28 HE
|
Novozymes A/S
June 6, 2024Company announcement No. 20 Incentive program for the Executive Leadership Team 2024-2026 In line with previous year, a new long-term incentive program (LTI) for the...
Trading by management and close relations of management
31 mai 2024 05h26 HE
|
Novozymes A/S
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Trading by management and close relations of management
29 mai 2024 10h59 HE
|
Novozymes A/S
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Trading by management and close relations of management
17 mai 2024 06h39 HE
|
Novozymes A/S
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Trading by management and close relations of management
08 mai 2024 09h21 HE
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_16_Trading_By_Management
...
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration
03 mai 2024 01h57 HE
|
Novozymes A/S
For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA...